Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Griffith

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Journal of Virology|May 31, 2019
Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 DefensesGaelle Picarda, Raima Ghosh, Bryan McDonald, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 25, 2010
Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonistThomas S Griffith, Tamara A Kucaba, Michael A O'Donnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2016
Gut Microbial Membership Modulates CD4 T Cell Reconstitution and Function after SepsisJavier Cabrera-Perez, Jeffrey C Babcock, Thamotharampillai Dileepan, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2014
CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinomaBritnie R James, Kristin G Anderson, Erik L Brincks, et al.
Journal of Cellular Biochemistry|February 6, 2008
Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetesAhter Dilsad Sanlioglu, Thomas S Griffith, Abdulkadir Omer, et al.
Journal of Leukocyte Biology|December 8, 2004
Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cellsBernd Jahrsdörfer, James E Wooldridge, Sue E Blackwell, et al.
International Journal of Cancer|September 23, 2006
Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapyJulieann F Grant, Toshihisa Iwasawa, Haley W Sinn, et al.
Current Protocols|July 10, 2024
Correction: Mouse Models of SepsisShravan Kumar Kannan, Caleb Y Kim, Mohammad Heidarian, et al.
Current Gene Therapy|March 12, 2009
TRAIL gene therapy: from preclinical development to clinical applicationThomas S Griffith, Brittany Stokes, Tamara A Kucaba, et al.
Gene Therapy|March 11, 2018
HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetesHale M Tasyurek, Yunus E Eksi, Ahter D Sanlioglu, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Journal of Virology|May 31, 2019
Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 DefensesGaelle Picarda, Raima Ghosh, Bryan McDonald, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 25, 2010
Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonistThomas S Griffith, Tamara A Kucaba, Michael A O'Donnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2016
Gut Microbial Membership Modulates CD4 T Cell Reconstitution and Function after SepsisJavier Cabrera-Perez, Jeffrey C Babcock, Thamotharampillai Dileepan, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2014
CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinomaBritnie R James, Kristin G Anderson, Erik L Brincks, et al.
Journal of Cellular Biochemistry|February 6, 2008
Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetesAhter Dilsad Sanlioglu, Thomas S Griffith, Abdulkadir Omer, et al.
Journal of Leukocyte Biology|December 8, 2004
Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cellsBernd Jahrsdörfer, James E Wooldridge, Sue E Blackwell, et al.
International Journal of Cancer|September 23, 2006
Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapyJulieann F Grant, Toshihisa Iwasawa, Haley W Sinn, et al.
Current Protocols|July 10, 2024
Correction: Mouse Models of SepsisShravan Kumar Kannan, Caleb Y Kim, Mohammad Heidarian, et al.
Current Gene Therapy|March 12, 2009
TRAIL gene therapy: from preclinical development to clinical applicationThomas S Griffith, Brittany Stokes, Tamara A Kucaba, et al.
Gene Therapy|March 11, 2018
HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetesHale M Tasyurek, Yunus E Eksi, Ahter D Sanlioglu, et al.
Pageof 18